Concepedia
Statistics
Publications
7
Citations
425
H-Index
Active since
1976
Affiliations
Idera Pharmaceuticals (United States)(Current)
California Polytechnic State University
Novartis (Switzerland)
Robert K. Smidt is an author at Idera Pharmaceuticals (United States) specializing in apoptosis, pharmacology, and potency optimization.
Publications per year
1976–2004
Assessing the validity and reliability of descriptor variables used in scenic highway analysis
Gary R. Clay, Robert K. Smidt · Landscape and Urban Planning · 2003 · 173 citations
Humanities, Civil Engineering, Psychometrics +6
Bcl-xL Functions Downstream of Caspase-8 to Inhibit Fas- and Tumor Necrosis Factor Receptor 1-induced Apoptosis of MCF7 Breast Carcinoma Cells
Anu Srinivasan, Feng Li, Angela Wong et al. · Journal of Biological Chemistry · 1998 · 160 citations · Full text
Life Sciences, Cell Biology, Oncology +17
Acyl dipeptides as reversible caspase inhibitors. Part 1: Initial Lead Optimization
Steven D. Linton, Donald S. Karanewsky, Robert J. Ternansky et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 33 citations · Full text
Pharmacy, Chemistry, Medicinal Chemistry +13
Oxamyl dipeptide caspase inhibitors developed for the treatment of stroke
Steven D. Linton, Teresa Aja, Peter R. Allegrini et al. · Bioorganic & Medicinal Chemistry Letters · 2004 · 21 citations · Full text
Medicine, Neuroscience, Pharmacology +11
Acyl dipeptides as reversible caspase inhibitors. Part 2: further optimization
Steven D. Linton, Donald S. Karanewsky, Robert J. Ternansky et al. · Bioorganic & Medicinal Chemistry Letters · 2002 · 17 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +13
1–5 of 7